Physician

Matthew Lonergan, MD

According to 2025 Medicare claims, Matthew Lonergan, MD (NPI: 1639122591) practices hematology/oncology in the Eugene-Springfield, OR market, with the plurality of this provider's patient population coming from Lane, OR. This provider's primary affiliated billing organization is ONCOLOGY ASSOCIATES OF OREGON P C (NPI: 1013989854; TIN: 930746296) and primary practice location at 97401-6036.

Lonergan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 541 traditional Medicare patients, billed 134,800 HCPCS/CPT codes, and received $2,401,135 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,205 prescription claims across 231 beneficiaries totaling $2,872,860 in drug costs, led by Calquence (Acalabrutinib Maleate). 2021 DME data shows 29 claims. Open Payments data shows 9 records totaling $3,167. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $180,349 to $2,401,135. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,073,853 to $2,872,860. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2015 Medicare payment: $180,349 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $786,007 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,211,246 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,756,712 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,980,035 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,983,398 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,768,825 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,277,877 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,339,086 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,401,135 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201533513,826$180,349
201638367,666$786,007
201737173,279$1,211,246
201844596,027$1,756,712
2019482106,044$1,980,035
2020485118,390$1,983,398
2021445110,284$1,768,825
202236377,841$1,277,877
202338875,663$1,339,086
2024541134,800$2,401,135

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.9M2015 Drug cost: $1,073,853 (USD; Tot_Drug_Cst)2016 Drug cost: $635,454 (USD; Tot_Drug_Cst)2017 Drug cost: $831,489 (USD; Tot_Drug_Cst)2018 Drug cost: $1,475,259 (USD; Tot_Drug_Cst)2019 Drug cost: $1,884,609 (USD; Tot_Drug_Cst)2020 Drug cost: $2,593,423 (USD; Tot_Drug_Cst)2021 Drug cost: $2,005,585 (USD; Tot_Drug_Cst)2022 Drug cost: $2,273,898 (USD; Tot_Drug_Cst)2023 Drug cost: $2,172,119 (USD; Tot_Drug_Cst)2024 Drug cost: $2,872,860 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015106700$1,073,853
2016165770$635,454
2017152918$831,489
2018165976$1,475,259
20191751,163$1,884,609
20202101,296$2,593,423
20211991,252$2,005,585
20221871,033$2,273,898
20231921,020$2,172,119
20242311,205$2,872,860

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.8K$7.6K2015 Medicare payment: $4,910 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $207 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $7,605 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $5,757 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,390 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R40$4,910
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R11$207
2019N/R70$7,605
2020N/R71$5,757
2021N/R29$3,390
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less146356$104
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more152506$69
80053Blood test, comprehensive group of blood chemicals299948$10
36415Insertion of needle into vein for collection of blood sample3201,080$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3031,048$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CalquenceAcalabrutinib Maleate25750$362,133
BrukinsaZanubrutinib24720$358,176
InlytaAxitinib16480$323,349
TagrissoOsimertinib Mesylate14420$253,304
LenalidomideLenalidomide12336$148,396

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$917INTUITIVE SURGICAL, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.2$2,250GlaxoSmithKline, LLC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Lonergan, MD?

Tedicare shows public-source Medicare data for Matthew Lonergan, MD (NPI 1639122591), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Lonergan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Lonergan, MD?

Matthew Lonergan, MD is linked to ONCOLOGY ASSOCIATES OF OREGON P C (billing NPI 1013989854) in the available physician profile data.

Does Matthew Lonergan, MD have Open Payments data?

Matthew Lonergan, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.